Factors that influence whether patients with cancer involve families in decision-making identified
the ONA take:
According to a new study published in the journal Cancer, researchers from Harvard Medical School in Boston, Massachusetts, have identified certain factors that influence whether patients with cancer involve their family members in treatment decisions.
For the study, researchers surveyed 5,284 patients with newly diagnosed colon or lung cancer, and asked them how they involved their family members in treatment decisions.
Results showed that only 1.5% of participants reported family-controlled decisions, while 49.4% reported equally sharing decisions with family members, 22.1% report some input from family members, and 28.5% reported little to no input from family members.
The researchers also found that non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to equally share decisions with their family members compared with other patients.
Patients who were female, insured, married, and older were also more often to equally share decisions with their family members versus other patients, while veterans were least likely to involve family members in treatment decisions.
The authors hope that the findings will help physicians to better assess their patients' preferences for involving their families in treatment decisions.
Certain factors influence whether patients with cancer involve their family members in treatment decisions.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- TKI-intolerant Patients With CLL Can Successfully Receive an Alternate TKI
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|